What is neonatal obstructive jaundice?

Neonatal obstructive jaundice due to biliary atresia is a hepatobiliary disorder caused by abnormal development of the biliary tract in newborns. Obstruction of bile flow leads to accumulation of bilirubin and persistent jaundice. This condition does not resolve spontaneously; delayed diagnosis and treatment may result in hepatic dysfunction. Persistent jaundice beyond the neonatal period and pale or clay-colored stools warrant prompt medical evaluation.

Neonatal obstructive jaundice is most commonly caused by biliary atresia or congenital biliary tract malformations, resulting in impaired bile drainage into the intestine and subsequent disruption of normal metabolic processes. Affected infants exhibit persistent jaundice from birth that fails to resolve spontaneously over time, often accompanied by pale stools and darkened urine. Prolonged cholestasis causes progressive hepatocellular injury, gradually impairing normal hepatic metabolic function and potentially leading to irreversible liver damage in severe cases.

Clinically, surgical intervention is the primary treatment for this condition, aimed at early restoration of biliary patency and normal bile flow. In mild cases, timely surgical correction of biliary anatomy can restore normal hepatobiliary function. However, in infants with prolonged disease duration, hepatic injury becomes more severe, significantly increasing the difficulty of recovery; some patients may require additional supportive therapies to stabilize liver function.

In daily care, closely monitor the infant’s skin and scleral coloration, ensure regular feeding to support metabolic activity, maintain perianal skin cleanliness, and document stool and urine color changes—thereby fostering a stable metabolic environment conducive to recovery.